The misregulation of Sik2 and Sik3 being detected in several cancer cases [39, 48] at both genetic and epigenetic levels [69], and Sik3 being established as an ovary cancer marker [70] are consistent with our finding that Siks can promote tumorigenesis. This evidence concerns the gene SIK2 and ovarian cancer.